By Kamal Choudhury Feb 9 (Reuters) - Privately held Iambic said on Monday it has entered a multi-year partnership worth more than $1.7 billion with Japan's Takeda Pharmaceutical to use artificial ...

Asad Awan, who is in charge of monetization at OpenAI was interviewed by his own company on "The Thinking Behind Ads in ...

Emma Betsinger discusses her adoption, surgeries and scars as she joins 'Love Is Blind' season 10 and finds connection and ...

Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs through a multi-year tech and ...

THX Pharma (Theranexus), an innovative biopharmaceutical company focused on the treatment of rare neurological diseases, announces that it will host a live webinar on Tuesday, February 17 at 6:00 p.m.

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex Lyon, France - February 12, 2026 - 6:00 p.m. CET - THX Pharma (Theranexus), an innovative biopharmaceutical company ...

4,821,879 reviews on ConsumerAffairs are verified. We require contact information to ensure our reviewers are real. We use intelligent software that helps us maintain the integrity of reviews. Our ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...